Biotech news
Americas
US law firm Blank Rome has hired Paul Zagar as a partner to its intellectual property group. 17 June 2015
Americas
An enormous increase in the number of biotech articles published in Brazil indicates that the area is experiencing strong expansion when considered in the global context, as Gabriel Di Blasi and Marisa Moura Momoli of Di Blasi, Parente & Associados report. 16 June 2015
Asia-Pacific
There is increasing demand for plant variety protection in Brazil. Renata Campello Afonso of Luiz Leonardos & Advogados reports. 16 June 2015
Biotech
The Enlarged Board of Appeal of the European Patent Office has issued the second decisions in the so-called Broccoli and Tomato cases. Albrecht von Menges of Uexküll & Stolberg examines the decisions and their implications. 16 June 2015
Americas
Mexican patent examiners usually reject patents directed to human embryonic stem cells, but applications filed after 2008 may have a greater chance of being approved, as Jasmin Maqueda of Becerril, Coca & Becerril describes. 16 June 2015
Americas
The inter partes review system was set up as a cheaper way of invalidating patents than litigation. Given the high success rate, and the large number of ‘patent trolls’ involved, is it likely that troll activity will be dampened? Steve Coyle, Leslie-Anne Maxwell and Chad Dever of Cantor Colburn investigate. 16 June 2015
Americas
The pharmaceutical and biotechnology industries are in “very good shape” and the so-called patent cliff is “firmly in the rear view mirror”, according to a report by life sciences market research company Evaluate. 16 June 2015
Americas
As far we know, the IP chapter in the proposed Trans-Pacific Partnership agreement contains provisions on modernising plant breeders’ rights, but not all the participating countries are currently on the same page, as LSIPR reports. 16 June 2015
Pharma
How will the OECD’s Modified Nexus Approach to innovator-friendly tax regimes such as the UK’s patent box affect the life sciences industry? LSIPR investigates. 16 June 2015
Americas
The antibiotics market could lose out for a decade due to inadequate research and development in the area, according to a report published by UK law firm Marks & Clerk today, June 16. 16 June 2015